Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

BACKGROUND: Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although no effective targeted therapies are available to date, about one-third of patients with TNBC achieve pathologic complete response (pCR) from standard-of-care anthracycline/taxane (ACT) che...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS Med
Главные авторы: Jiang, Tingting, Shi, Weiwei, Wali, Vikram B., Pongor, Lőrinc S., Li, Charles, Lau, Rosanna, Győrffy, Balázs, Lifton, Richard P., Symmans, William F., Pusztai, Lajos, Hatzis, Christos
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2016
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154510/
https://ncbi.nlm.nih.gov/pubmed/27959926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002193
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы